| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 10/20/2009 | US7605313 Plants and seeds of corn variety CV590239 |
| 10/20/2009 | US7605312 Plants and seeds of corn variety CV971868 |
| 10/20/2009 | US7605311 Plants and seeds of hybrid corn variety CH407425 |
| 10/20/2009 | US7605310 Inbred corn line BC5 |
| 10/20/2009 | US7605303 cloning a rice stress-responsive gene, RSI, using the isolated gene to breed NaCl and drought resistance plant but not resistance to abscisic acid; genetic engineering |
| 10/20/2009 | US7605280 1,5-Bis-((2-dimethylamino-N-oxide)ethyl)amino)-4,8-dihydroxyanthracene-9,10-dione; DRAQ5 dyes;analyzing cells/biological material and detecting emitted fluorescence signal; cell permeant DNA-interactive agents providing a fluorescence signature into the infra red spectra; red-line emitting lasers |
| 10/20/2009 | US7605253 field of combination oligomers, including the block synthesis of combination oligomers in the absence of a template, as well as related methods, kits, libraries and other compositions. |
| 10/20/2009 | US7605252 siRNA targeting kinase insert domain receptor (KDR) |
| 10/20/2009 | US7605251 an RNA strand (the antisense strand) having a region which is less than 30 nucleotides in length, complementary to at least a part of the PCSK9 gene; antihyperlipemia agent |
| 10/20/2009 | US7605250 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA |
| 10/20/2009 | US7605249 To deliver specifically tailored small interfering RNA as therapeutic agents for treatment of Parkinson's disease |
| 10/20/2009 | US7605248 Recombinant constructs of Borrelia burgdorferi |
| 10/20/2009 | US7605246 Genes differentially expressed in breast cancer |
| 10/20/2009 | US7605245 PUFA polyketide synthase systems and uses thereof |
| 10/20/2009 | US7605244 Gamma tocopherol methyltransferase coding sequence from Brassica and uses thereof |
| 10/20/2009 | US7605243 With reporter moieties including azo quenchers, fluorophores, biotin, digoxigenin, peptides and proteins; kits |
| 10/20/2009 | US7605138 Nucleic acid compositions for stimulating immune responses |
| 10/20/2009 | US7605131 EML4-ALK fusion gene |
| 10/20/2009 | US7605003 Using apolipoprotein A1 (Apo A1), a truncated form of transthyretin, ("transthyretin Delta N10) and/or a cleavage fragment of inter- alpha -trypsin inhibitor heavy chain H4 (IAIH4 fragment) as diagnostic/prognostic indicators of cell proliferative disorders of urogenital systems |
| 10/20/2009 | US7605000 Invention provides a DNA molecule capable of expressing a heterologous polypeptide under cold shock conditions, where the DNA molecule is preferably a self-replicating expression vector |
| 10/20/2009 | US7604996 Compositions and methods for preparing oligonucleotide solutions |
| 10/20/2009 | US7604995 Compositions, kits, and methods for stimulation of homologous recombination |
| 10/20/2009 | US7604994 Genetically altered antibody-producing cell lines with improved antibody characteristics |
| 10/20/2009 | US7604982 High-throughput screening method for intergrin antagonist and new peptide screened therefrom |
| 10/20/2009 | US7604977 Inhibiting HIV replication in an HIV-infected cell by contacting the cell with a compound which down-regulates expression of an isopeptidase T-encoding gene, thereby inhibiting HIV replication in the cell |
| 10/20/2009 | US7604976 Fragments of a plant genome; controlling the expression of a gene; tools for genetic mapping; recognizing or isolating identical or related DNA fragments; identification of a particular individual organism; clustering of a group of organisms with a common trait |
| 10/20/2009 | US7604973 Lyases; bactericides; gene knockout; animal husbandry; use of nucleic acid segment in the preparation of recombinant cells which produce hyaluronate synthase and its hyaluronic acid product |
| 10/20/2009 | US7604971 Sequence-determined DNA fragments encoding UBIE/COQ5 methyltransferase family proteins |
| 10/20/2009 | US7604970 Variants of the PapM polypeptide of bacteria of the Streptomyces genus |
| 10/20/2009 | US7604969 improved substrate specificity to glucose, amino acid sequence having the substitution, deletion, insertion or addition of one or more amino acid residues excluding amino acid 365 in the amino acid sequence |
| 10/20/2009 | US7604963 Using surface plasmon resonance and raman spectroscopy as tools in determining sequence of preferential polynucleotides |
| 10/20/2009 | US7604959 Cell-based assays employing voltage and calcium dyes |
| 10/20/2009 | US7604940 Compositions and methods for analyzing isolated polynucleotides |
| 10/20/2009 | US7604937 Polymerase chain reactions; multiplexing |
| 10/20/2009 | US7604810 Conserved Neisserial antigens |
| 10/20/2009 | US7604803 Codelivery to a cell of nucleic acid and assistor protein (antigen) where the nucleic acid encodes an antigenic protein or which shares an epitope(s) with the assistor protein; the nucleic acid is entrapped in liposome intravesicular space; assistor protein is on the liposome surface; synergistic |
| 10/20/2009 | US7604798 Methods and compositions for importing nucleic acids into cell nuclei |
| 10/20/2009 | CA2384407C 2-azapurine compounds and their use |
| 10/20/2009 | CA2330363C Diacylglycerol o-acyltransferase |
| 10/15/2009 | WO2009126883A2 Nucleic acid binding substance containing catalytic nucleation nanoparticles |
| 10/15/2009 | WO2009126727A1 Rna compositions for modulating immune response |
| 10/15/2009 | WO2009126651A2 Mat ii subunit rnai and therapeutic methods using same |
| 10/15/2009 | WO2009126517A2 Optimized probes and primers and methods of using same for the detection, quantification and grouping of hiv-1 |
| 10/15/2009 | WO2009126395A1 Method for identifying the sequence of one or more variant nucleotides in a nucleic acid molecule |
| 10/15/2009 | WO2009125986A2 Lyophilized dna formulations for enhanced expression of plasmid dna |
| 10/15/2009 | WO2009124396A1 Polymorphisms predictive of platinum-coordinating compound-induced ototoxicity |
| 10/15/2009 | WO2008098198A8 Alkane oxidation by modified hydroxylases |
| 10/15/2009 | US20090260111 Maize Stress-Responsive Promoter |
| 10/15/2009 | US20090260109 Methods of increasing abiotic stress tolerance and/or biomass in plants genterated thereby |
| 10/15/2009 | US20090260106 Antifungal polypeptides |
| 10/15/2009 | US20090260103 Termination of transgene expression via transposon-mediated break |
| 10/15/2009 | US20090260095 Gene Marker for Evaluating Genetic Ability for Carcass Weight in Bovine and Method for Evaluating Genetic Ability for Carcass Weight Using the Same |
| 10/15/2009 | US20090260094 Stearoyl-CoA Desaturase 4 Gene |
| 10/15/2009 | US20090260092 Methods of diagnosing alzheimer's disease and markers identified by set association |
| 10/15/2009 | US20090260090 Apobec3 mediated dna editing |
| 10/15/2009 | US20090259035 Method for producing recombinant RNase A |
| 10/15/2009 | US20090259031 CHIMERIC AND HUMANIZED ANTIBODIES TO alpha5beta1 INTEGRIN THAT MODULATE ANGIOGENESIS |
| 10/15/2009 | US20090259030 Stabilized nucleic acid dark quencher-fluorophore probes |
| 10/15/2009 | US20090259027 Human GM-CSF antibodies |
| 10/15/2009 | US20090259019 Masp-2, a complement fixing enzyme, and uses for it |
| 10/15/2009 | US20090258934 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE |
| 10/15/2009 | US20090258931 Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry |
| 10/15/2009 | US20090258930 Double stranded rna structures and constructs, and methods for generating and using the same |
| 10/15/2009 | US20090258927 Method for the Modulation of Function of Transcription Factors |
| 10/15/2009 | US20090258925 Natural antisense and non-coding rna transcripts as drug targets |
| 10/15/2009 | US20090258848 Biomarkers for inflammatory bowel disease |
| 10/15/2009 | US20090258832 Cytokines and Cytokine Receptors With Reduced Immunocencity |
| 10/15/2009 | US20090258826 Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use |
| 10/15/2009 | US20090258819 Reagents and Methods for Smooth Muscle Therapies |
| 10/15/2009 | US20090258425 Gene knock-down by intracellular expression of aptamers |
| 10/15/2009 | US20090258424 Cellular Delivery of siRNA |
| 10/15/2009 | US20090258420 Altered polypeptides, immunoconjugates thereof, and methods related thereto |
| 10/15/2009 | US20090258418 Reactive 1,3'-crosslinked carbocyanines and their bioconjugates |
| 10/15/2009 | US20090258410 Methods for producing soluble membrane spanning proteins |
| 10/15/2009 | US20090258400 Mutant Tyrosine Repressor, a Gene Encoding the Same, and a Method for Producing L-Dopa |
| 10/15/2009 | US20090258389 Construction of New Variants of Dextransucrase DSR-S by Genetic Engineering |
| 10/15/2009 | US20090258374 Multisignal Labeling Reagents, and Processes and Uses Therefor |
| 10/15/2009 | US20090258363 Targeted integration and expression of exogenous nucleic acid sequences |
| 10/15/2009 | US20090258357 identifying a binding partner to a cytokine receptor common gamma chain like (CRCGCL) polypeptide encoded by a cDNA; for diagnosis and treatment autoimmune disorders |
| 10/15/2009 | US20090258353 PCR primer capable of reducing non-specific amplification and PCR method using the PCR primer |
| 10/15/2009 | US20090258351 Methods and Reagents for Combined PCR Amplification |
| 10/15/2009 | US20090258346 Method of selecting sunflower genotypes with high oleic acid content in seed oil |
| 10/15/2009 | US20090258344 Methods for identifying risk of breast cancer and treatments thereof |
| 10/15/2009 | US20090258342 Optimized probes and primers and methods of using same for the detection, quantification and grouping of hiv-1 |
| 10/15/2009 | US20090258339 Systems, methods and compositions for detection of human papilloma virus in biological samples |
| 10/15/2009 | US20090258036 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3' -utr of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4 |
| 10/15/2009 | US20090258031 fusion protein comprising polypeptide with a human immunoglobulin (Ig) polypeptide; has an ability to bind CD80 or CD86 or an extracellular domain of either CD80 or CD86, and/or an ability to inhibit a T cell immune response |
| 10/15/2009 | US20090258021 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 10/15/2009 | US20090258012 Compositions and methods for treating inflammatory disorders |
| 10/15/2009 | US20090258007 Anti-Perp Antibody |
| 10/15/2009 | US20090258005 Therapeutic compositions and methods |
| 10/15/2009 | US20090258002 Biomarkers for Tissue Status |
| 10/15/2009 | US20090257990 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 10/15/2009 | US20090257952 Engineered Integrin Binding Peptides |
| 10/15/2009 | CA2740950A1 Polymorphisms predictive of platinum-coordinating compound-induced ototoxicity |
| 10/15/2009 | CA2721313A1 Method and apparatus for determining a probability of colorectal cancer in a subject |
| 10/15/2009 | CA2721183A1 Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components |
| 10/15/2009 | CA2720611A1 Lyophilized dna formulations for enhanced expression of plasmid dna |
| 10/14/2009 | EP2108707A2 Molecular identification of Aspergillus Species |
| 10/14/2009 | EP2108694A1 Cyanobacterial nucleic acid fragments encoding proteins useful for controlling plant traits via nuclear or plastome transformation |